Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
New perspectives in the renin-angiotensin-aldosterone system (RAAS) IV: circulating ACE2 as a biomarker of systolic dysfunction in human hypertension and heart failure.
PLoS One. 2014 Apr 1;9(4):e87845. doi: 10.1371/journal.pone.0087845. eCollection 2014.
PLoS One. 2014.
PMID: 24691269
Free PMC article.
New perspectives in the renin-angiotensin-aldosterone system (RAAS) III: endogenous inhibition of angiotensin converting enzyme (ACE) provides protection against cardiovascular diseases.
Fagyas M, Úri K, Siket IM, Daragó A, Boczán J, Bányai E, Édes I, Papp Z, Tóth A.
Fagyas M, et al. Among authors: uri k.
PLoS One. 2014 Apr 1;9(4):e93719. doi: 10.1371/journal.pone.0093719. eCollection 2014.
PLoS One. 2014.
PMID: 24690767
Free PMC article.
Item in Clipboard
New perspectives in the renin-angiotensin-aldosterone system (RAAS) I: endogenous angiotensin converting enzyme (ACE) inhibition.
Fagyas M, Úri K, Siket IM, Daragó A, Boczán J, Bányai E, Édes I, Papp Z, Tóth A.
Fagyas M, et al. Among authors: uri k.
PLoS One. 2014 Apr 1;9(4):e87843. doi: 10.1371/journal.pone.0087843. eCollection 2014.
PLoS One. 2014.
PMID: 24691160
Free PMC article.
Item in Clipboard
New perspectives in the renin-angiotensin-aldosterone system (RAAS) II: albumin suppresses angiotensin converting enzyme (ACE) activity in human.
Fagyas M, Úri K, Siket IM, Fülöp GÁ, Csató V, Daragó A, Boczán J, Bányai E, Szentkirályi IE, Maros TM, Szerafin T, Édes I, Papp Z, Tóth A.
Fagyas M, et al. Among authors: uri k.
PLoS One. 2014 Apr 1;9(4):e87844. doi: 10.1371/journal.pone.0087844. eCollection 2014.
PLoS One. 2014.
PMID: 24691203
Free PMC article.
Item in Clipboard
Circulating ACE2 activity correlates with cardiovascular disease development.
Úri K, Fagyas M, Kertész A, Borbély A, Jenei C, Bene O, Csanádi Z, Paulus WJ, Édes I, Papp Z, Tóth A, Lizanecz E.
Úri K, et al.
J Renin Angiotensin Aldosterone Syst. 2016 Dec 12;17(4):1470320316668435. doi: 10.1177/1470320316668435. Print 2016 Oct.
J Renin Angiotensin Aldosterone Syst. 2016.
PMID: 27965422
Free PMC article.
Item in Clipboard
Changes in the SARS-CoV-2 cellular receptor ACE2 levels in cardiovascular patients: a potential biomarker for the stratification of COVID-19 patients.
Fagyas M, Bánhegyi V, Úri K, Enyedi A, Lizanecz E, Mányiné IS, Mártha L, Fülöp GÁ, Radovits T, Pólos M, Merkely B, Kovács Á, Szilvássy Z, Ungvári Z, Édes I, Csanádi Z, Boczán J, Takács I, Szabó G, Balla J, Balla G, Seferovic P, Papp Z, Tóth A.
Fagyas M, et al. Among authors: uri k.
Geroscience. 2021 Oct;43(5):2289-2304. doi: 10.1007/s11357-021-00467-2. Epub 2021 Oct 21.
Geroscience. 2021.
PMID: 34674152
Free PMC article.
Item in Clipboard
TXNL1 has dual functions as a redox active thioredoxin-like protein as well as an ATP- and redox-independent chaperone.
Andor A, Mohanraj M, Pató ZA, Úri K, Biri-Kovács B, Cheng Q, Arnér ESJ.
Andor A, et al. Among authors: uri k.
Redox Biol. 2023 Nov;67:102897. doi: 10.1016/j.redox.2023.102897. Epub 2023 Sep 26.
Redox Biol. 2023.
PMID: 37804695
Free PMC article.
Item in Clipboard
Cite
Cite